2004
DOI: 10.1016/s0149-2918(04)90050-1
|View full text |Cite
|
Sign up to set email alerts
|

Once-daily budesonide aqueous nasal spray for allergic rhinitis: A review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
18
0

Year Published

2007
2007
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 29 publications
(20 citation statements)
references
References 56 publications
0
18
0
Order By: Relevance
“…Antihistamines are widely used for AR treatment and are effective in relieving sneezing, rhinorrhea, and itching although they have little effect on nasal congestion and are most effective when ocular symptoms are prominent 15,16 . They control symptoms of the early-phase inflammatory response through the action on histamine1 receptors while they have no effect on the late-phase inflammatory response and on the underlying inflammatory process 16 .…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Antihistamines are widely used for AR treatment and are effective in relieving sneezing, rhinorrhea, and itching although they have little effect on nasal congestion and are most effective when ocular symptoms are prominent 15,16 . They control symptoms of the early-phase inflammatory response through the action on histamine1 receptors while they have no effect on the late-phase inflammatory response and on the underlying inflammatory process 16 .…”
Section: Discussionmentioning
confidence: 99%
“…They control symptoms of the early-phase inflammatory response through the action on histamine1 receptors while they have no effect on the late-phase inflammatory response and on the underlying inflammatory process 16 . INSs have been shown to be the most useful treatment for AR and they are effective against the entire spectrum of AR symptoms since they inhibit both the early-and late-phase inflammatory responses 15,16 .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Fluticasone propionate is approved for children aged 4 years and older (2213, [2220][2221][2222], and other intranasal glucocorticosteroids may be used in those over the age of 5 years (1518,2223,2224).…”
Section: Treatmentmentioning
confidence: 99%
“…Intranasal corticosteroids are usually formulated and administered via an isotonic medium [16-18] However, ciclesonide is formulated in a hypotonic suspension. The viscous consistency of the hypotonic suspension provides longer retardation of ciclesonide on nasal mucosa and a high local concentration of ciclesonide to increase its absorption into nasal mucosa [19].…”
Section: Introductionmentioning
confidence: 99%